Accessible Version

Science for the Brain
The nation's leading supporter of biomedical research on disorders of the brain and nervous system

Browse all disorders

Browse all health
   organizations

More about
   a disorder
Studies with patients
Research literature
Press releases

Disclaimer

(help)
Contact us
My privacy

NINDS is part of the
National Institutes of
Health

 
Press Releases

Trial Drugs for Huntington's Disease Inconclusive in Slowing Disease
Monday, August 13, 2001
A large-scale clinical trial that tested the ability of the investigational drugs remacemide and Coenzyme Q10 to slow the progression of Huntington's disease showed that neither drug resulted in any significant improvement for the patients. Although after one year of treatment, the disease seemed to progress more slowly in patients treated with Coenzyme Q10, the investigators say that overall the results are inconclusive as to whether there is real benefit from this drug.
Grant | Fact Sheet 

Scientists Identify Gene for Spinocerebellar Ataxia 2
Thursday, October 31, 1996
Scientists have identified the gene altered in one of the most common hereditary ataxias, spinocerebellar ataxia 2 (SCA2). The discovery allows improved genetic testing and provides new clues about how genetic mutations cause several neurological disorders, including Huntington's disease. The findings are reported by three different groups in the November issue of Nature Genetics.
 



National Institute of Neurological Disorders and Stroke
Home | About NINDS | Disorders | Funding | News & Events | Find People | Jobs & Training | Accessibility
H H S Logo - link to U. S. Department of Health and Human Services     N I H logo - link to U. S. National Institutes of Health    N I N D S logo - link to National Institute of Neurological Disorders and Stroke    FirstGov Logo - link To FirstGov